Aman Chauhan/X
May 30, 2025, 00:51
Aman Chauhan: Let’s Talk Neuroendocrine Oncology and Radiopharmaceuticals at ASCO25
Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared a post X:
“Let’s talk neuroendocrine oncology and Radiopharmaceuticals over a cup of coffee in beautiful Chicago. See ya soon. And don’t forget to checkout our ASCO25 abstracts.
DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results. Racial and ethnic disparities in US neuroendocrine tumor clinical trial enrollment over the past quarter century.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20